Novartis Ships Influenza Virus Vaccines to US
Posted on: Friday, 8 August 2008, 12:00 CDT
Novartis has started shipments of its Fluvirin influenza virus vaccine to US health care facilities and practitioners for the 2008/2009 influenza season.
The company is producing up to 40 million doses of Fluvirin, with the World Health Organization recommended change in all three virus strains included in the influenza vaccine composition.
Novartis expects to deliver at least 20 million doses by the end of September 2008, when widespread vaccination campaigns usually begin, and strives to ship the remainder by October 31, 2008.
To help meet demand for influenza vaccine earlier in the season, Novartis now has a second manufacturing facility in Rosia, Italy, in addition to its Liverpool, England facility. The FDA recently granted approval to the Rosia facility to fill Fluvirin in pre-filled syringes.
Joerg Reinhardt, CEO of Novartis vaccines and diagnostics, said: "Novartis is committed to delivering high quality influenza vaccine to help protect more people against this potentially serious and contagious disease."
Source: Datamonitor
Related Articles
- Novartis Begins Shipment to US of Fluvirin(R) Influenza Virus Vaccine With Three New Strains for the 2008-2009 Influenza Season
- Medicago to Evaluate Establishment of a Pandemic Vaccine Production Facility in France in Collaboration With Genopole D'Evry in Paris
- Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones By Reserving an Influenza Vaccination
- FFF Enterprises Signs Three-Year Flu Vaccine Distribution Agreement With Novartis Vaccines (Formerly Chiron)
- FDA Approves MedImmune's State-of-the-Art Influenza Vaccine Manufacturing Facility
- Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customers
- Chiron Announces Favorable Results of FDA Inspection of FLUVIRIN(R) Influenza Virus Vaccine Manufacturing Facility
- Chiron Will Not Supply BEGRIVAC(TM) Influenza Virus Vaccine to Non-U.S. Markets
- FDA On-Site Inspection of Chiron's FLUVIRIN(R) Influenza Virus Vaccine Facility Underway
 |
 |
User Comments (0)
RSS Feeds